Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

AMS vs AMD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AMD Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

AMD Overall Winner 6-Pillar Tally: AMS 0 – 6 AMD Matrix Metrics: AMS 2 – 8 AMD

As of Nov 16, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over American Shared Hospital Services (AMS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMS carries a Unified Composite Score of 33.8/100 (SELL) at $1.07 (44.6x Forward P/E, -7.4% operating margin), whereas AMD carries 48.7/100 (HOLD) at $504.28 (28.5x Forward P/E, 17.8% operating margin).

  • Technical & Structure Timing Caution: AMS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.1); meanwhile AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 46.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AMS vs AMD
AMS NYSE American
American Shared Hospital Services
Services-Medical Laboratories
$1.07
-0.93% 1D
Market Cap $7.2M
TTM Revenue $30M
Forward P/E 44.6x
Beta / 30D Vol 0.18β · 46% Vol
Unified Composite Score
33.8 / 100 SELL
Tech 24.0 Fund 38.0 Flow 50.0 Mom 30.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.9%), weak momentum, RSI 27
RSI-14: 27.1 · SMA20: $1.21 · SMA50: $1.32
AMD NASDAQ Head-to-Head Winner
Advanced Micro Devices
Semiconductors & Related Devices
$504.28
-5.58% 1D
Market Cap $875.9B
TTM Revenue $45.4B
Forward P/E 28.5x
Beta / 30D Vol 3.59β · 118% Vol
Unified Composite Score
48.7 / 100 HOLD
Tech 22.0 Fund 42.0 Flow 68.0 Mom 37.6
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 46.8 · SMA20: $517.33 · SMA50: $555.09

6-Pillar Scorecard Institutional Category Breakdown (AMS 0 – 6 AMD)

Columns: Metric · AMS · AMD
1. Valuation Multiples AMD
Forward P/E 44.6x 28.5x
Trailing P/E 44.6x 114.1x
PEG Ratio N/M 0.48x
EV / Revenue 0.8x 19.3x
2. Growth & Scale AMD
Revenue Growth (YoY) +19.2% +44.7%
Earnings Growth (YoY) -38.1% +93.8%
TTM Revenue (USD) $30M $45.4B
Market Cap $7.2M $875.9B
3. Profitability & Quality AMD
Gross Margin 34.8% 56.0%
Operating Margin -7.4% 17.8%
Net Profit Margin -5.8% 16.8%
Return on Equity (ROE) -12.1% 12.0%
4. Balance Sheet & Cash Flow AMD
Cash Generation (TTM) -$916,000 $7.06B
Cash Flow Margin -3.0% 15.5%
Net Cash / Leverage $17M Net Debt (0.95x D/E) $1.51B Net Debt (0.13x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AMD
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 19.9% (3rd %ile)
Put/Call OI Skew N/A 1.07x (Balanced)
OBV Trend / Tech Phase NEUTRAL · Markdown ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat AMD
OpEx & R&D Intensity 42.2% of Rev ($13M) 38.2% of Rev ($17.4B)
90D R&D Disclosures 0 papers 7 papers
Competitive Moat Cyclical / Execution-Driven Positioning Concentrated Oligopoly Moat
Supply-Chain Role Medical Care Facilities Operator AI Accelerator & Server Chiplet Designer

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AMS (2) vs AMD (8)
Institutional Metric AMS AMD Criterion Row Edge
Market Capitalization
Scale
$7.2M $875.9B Larger Scale AMD
Trailing P/E Ratio
Valuation
44.6x 114.1x Lower Multiple AMS
Forward P/E Ratio
Valuation
44.6x 28.5x Lower Multiple AMD
Revenue Growth (YoY)
Growth
+19.2% +44.7% Higher Growth AMD
Operating Margin (TTM)
Profitability
-7.4% 17.8% Higher Margin AMD
Net Profit Margin
Profitability
-5.8% 16.8% Higher Margin AMD
Return on Equity (ROE)
Capital Efficiency
-12.1% 12.0% Higher ROE AMD
52-Week Range Position
Momentum
6% ($1–$2) 67% ($188–$659) Stronger Trend AMD
Beta / 30D Volatility
Risk Regime
0.18β · 46% Vol 3.59β · 118% Vol Lower Realized Risk AMS
Unified Institutional Score
Composite Signal
33.8 / 100 (SELL) 48.7 / 100 (HOLD) Higher Composite AMD
Trailing 12M Revenue (USD)
Operating Scale
$30M $45.4B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
34.8% 56.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.8x EV/Rev 0.48x PEG · 19.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$916,000 ($17M Net Debt (0.95x D/E)) $7.06B ($1.51B Net Debt (0.13x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AMD +11.78 pp
AMS: -16.41% · AMD: -4.63%
3M Horizon AMD +33.25 pp
AMS: -29.14% · AMD: +4.11%
6M Horizon AMD +43.35 pp
AMS: -23.57% · AMD: +19.78%
1Y Horizon AMD +155.6 pp
AMS: -52.23% · AMD: +103.37%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period AMS Revenue AMD Revenue AMS Op. Margin AMD Op. Margin Margin Leader
FY2018 $20M $6.47B 9.4% 7.0% AMS
FY2019 $20M $6.73B 7.5% 9.4% AMD
FY2020 $20M $9.76B -53.1% 14.0% AMD
FY2021 $20M $16.4B 7.7% 22.2% AMD
FY2022 $20M $23.6B 12.3% 5.4% AMS
FY2023 $20M $22.7B 1.3% 1.8% AMD
FY2024 $30M $25.8B -9.9% 7.4% AMD
FY2025 $30M $34.6B -12.8% 10.7% AMD

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AMS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AMS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AMD CONSOLIDATION
103d in phase · OBV ACCUMULATION
Current IV 19.9%
IV Percentile 3rd %ile
Put/Call OI Skew 1.07x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor $500.00
Call Wall Magnet $600.00
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Put Floor: $500.00 (-0.8%) Spot: $504.28 Call Magnet: $600.00 (+19.0%)
  • Extended consolidation (103 days)
  • IV expanding (+13.9%) - uncertainty/bearish
  • Near put wall support ($500)

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AMS Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $7.2M market capitalization and -7.4% operating margin.
OpEx & R&D Reinvestment 42.2% of Rev ($13M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries ASE Technology Holding Amkor Technology
AMD Moat Profile Concentrated Oligopoly Moat
AI Accelerator & Server Chiplet Designer
Data center GPU accelerators and server CPU chiplets scale directly with upstream leading-edge foundry utilization and cloud server integration.
OpEx & R&D Reinvestment 38.2% of Rev ($17.4B)
90D Engineering Disclosures 7 Published · LLM Efficiency / Architecture
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries Samsung Electronics ASE Technology Holding
Active 90D Technical Topics:
Edge AI / Inference Chips Hardware-Agnostic ML Compilers Inference Serving / Speculative Decoding KV-Cache / Attention Memory Compression Mixture-of-Experts / Sparse Models

Investor FAQ AMS vs AMD Key Questions & Quantitative Answers

As of Nov 16, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over American Shared Hospital Services (AMS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMS carries a Unified Composite Score of 33.8/100 (SELL) at $1.07 (44.6x Forward P/E, -7.4% operating margin), whereas AMD carries 48.7/100 (HOLD) at $504.28 (28.5x Forward P/E, 17.8% operating margin). Technical & Structure Timing Caution: AMS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.1); meanwhile AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 46.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AMD leads the Growth & Scale pillar: AMS posts +19.2% YoY revenue growth and -38.1% YoY earnings growth on $30M TTM revenue (34.8% gross margin, -7.4% operating margin), compared with AMD at +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), AMS cumulative revenue shifted +50.0% while AMD shifted +435.4%. In operating R&D and SG&A reinvestment, AMS deploys 42.2% of Rev ($13M) (0 90-day corporate R&D disclosures) versus 38.2% of Rev ($17.4B) (7 disclosures) for AMD.

AMD screens cheaper on headline valuation multiples. AMS trades at 44.6x Forward P/E, 44.6x Trailing P/E, N/M PEG, and 0.8x EV/Revenue (-3.0% FCF margin), whereas AMD trades at 28.5x Forward P/E, 114.1x Trailing P/E, 0.48x PEG, and 19.3x EV/Revenue (15.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMS (-12.1% ROE) versus AMD (12.0% ROE) capital efficiency.

In options market volatility and institutional positioning, AMS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.18β · 46% Vol realized risk). By comparison, AMD carries 19.9% implied volatility (3rd %ile, Compressed (<25th %ile)), a 1.07x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (3.59β · 118% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.